08048035968
Premium Exporter of Genuine EVENITY 105mg Injection from India to Singapore – Orchard | Phoenix Exim

1. General Information

EVENITY 105 mg Injection contains romosozumab, a monoclonal antibody used in the treatment of severe osteoporosis in postmenopausal women who have a high risk of fractures. It works by targeting sclerostin, a protein involved in the regulation of bone formation and bone breakdown.

EVENITY is a prescription-only medicine and treatment should be initiated and supervised by a healthcare professional experienced in osteoporosis management.

Exporter information: Phoenix Exim, Nagpur, India, supplies pharmaceutical products for international markets including the USA, UK, Australia, Singapore, Canada, South Korea and UAE, subject to applicable import, prescription and regulatory requirements.

2. Product Information

  • Brand: EVENITY
  • Active ingredient: Romosozumab
  • Strength: 105 mg
  • Dosage form: Solution for injection
  • Route: Subcutaneous injection
  • Therapeutic class: Medicine for bone diseases/osteoporosis
  • Mechanism: Sclerostin inhibition
  • Typical regimen: Two 105 mg injections, for a total of 210 mg, once monthly for 12 months in the EMA-approved regimen.
  • Manufacturer/marketing authorisation holder in the EU: UCB Pharma S.A.

3. Uses of EVENITY 105 mg Injection

EVENITY is used for the treatment of severe osteoporosis in postmenopausal women who are at high risk of fracture. Osteoporosis causes bones to become weaker and more susceptible to fractures.

The medicine may be considered particularly in patients with severe osteoporosis or a history of osteoporotic fracture, according to the applicable prescribing guidelines.

4. Benefits of EVENITY

Potential benefits include:

  • Helps stimulate the formation of new bone.
  • Helps reduce bone breakdown.
  • Increases bone strength and bone mineral density.
  • Helps reduce the risk of osteoporotic fractures.
  • Clinical studies demonstrated reductions in vertebral fractures compared with placebo and alendronate-based treatment strategies.

EVENITY is generally used for a limited 12-month course, after which an appropriate osteoporosis treatment is usually considered to maintain the bone-health benefits.

5. Side Effects of EVENITY

Like all medicines, EVENITY can cause side effects. Important potential adverse effects include:

  • Joint pain
  • Nasopharyngitis
  • Headache
  • Injection-site reactions
  • Hypocalcaemia (low blood calcium)
  • Hypersensitivity/allergic reactions
  • Cardiovascular events such as myocardial infarction or stroke

Cardiovascular risk is particularly important with romosozumab. In the EU, EVENITY must not be used in patients who have previously had a heart attack or stroke, and it must not be used in patients with hypocalcaemia.

6. Common Side Effects

Some of the more commonly reported adverse effects include:

  • Nasopharyngitis — inflammation/infection-like symptoms affecting the nose and throat
  • Arthralgia — joint pain
  • Injection-site reactions
  • Headache
  • Muscle or bone discomfort

The exact frequency and complete list of adverse reactions should be checked in the current product information for the country where the medicine is prescribed.

7. How to Use EVENITY

EVENITY is administered under the skin (subcutaneously) by a healthcare professional or according to the approved instructions for the particular product and country.

The EMA-approved regimen consists of two separate 105 mg injections (210 mg total) once every month for 12 months, with injections given at different body sites such as the abdomen, thigh or upper arm.

Patients should not change the dose, injection schedule or duration of treatment themselves. Calcium and vitamin D status should also be appropriately managed by the treating healthcare professional.

8. How This Medicine Works

EVENITY contains romosozumab, which binds to and inhibits sclerostin.

Sclerostin normally helps regulate bone metabolism. By blocking sclerostin, romosozumab:

Increases bone formation + decreases bone resorption → improves bone strength → helps reduce fracture risk.

This dual effect distinguishes romosozumab from medicines that primarily slow bone breakdown.

9. Safety Advice

Before treatment, patients should inform their doctor if they:

  • Have previously experienced a heart attack or stroke.
  • Have cardiovascular disease or significant cardiovascular risk factors.
  • Have low calcium levels.
  • Have kidney problems or are receiving dialysis.
  • Have a history of serious allergic reactions to medicines.
  • Are taking other osteoporosis medicines or calcium/vitamin D supplements.

Seek urgent medical attention if symptoms suggest a heart attack or stroke, or if signs of a severe allergic reaction occur.

Patients should also maintain adequate calcium and vitamin D intake when advised by their healthcare professional. Treatment should be prescribed and monitored by an appropriate medical specialist.

10. FAQs

Q1. What is EVENITY 105 mg Injection?
EVENITY 105 mg is a romosozumab injection used to treat severe osteoporosis in postmenopausal women at high risk of fracture.

Q2. What is the active ingredient in EVENITY?
The active ingredient is romosozumab.

Q3. How much EVENITY is given per dose?
The EMA regimen uses two 105 mg injections, providing a total dose of 210 mg once monthly.

Q4. How long is EVENITY treatment given?
The recommended course is generally 12 monthly doses. A subsequent osteoporosis treatment is typically considered to maintain the improvement in bone health.

Q5. Can EVENITY be self-administered?
Administration should follow the product's approved instructions and healthcare professional guidance. In the EU, treatment should be initiated and supervised by a specialist experienced in osteoporosis.

Q6. Who should not use EVENITY?
Important contraindications include patients with hypocalcaemia and, under the EU product information, patients with a previous myocardial infarction or stroke.

Q7. Does EVENITY help prevent fractures?
Yes. Clinical studies demonstrated reductions in vertebral fractures and other osteoporotic fracture outcomes in appropriate patients.

Q8. Is EVENITY a prescription medicine?
Yes. It is a prescription medicine and should be used under appropriate medical supervision.

11. Substitutes for EVENITY 105 mg

There is no universal one-to-one substitute for EVENITY because treatment selection depends on the patient's fracture risk, medical history, cardiovascular risk, kidney function and previous osteoporosis treatment.

Depending on the clinical situation, doctors may consider other osteoporosis medicines such as:

  • Alendronate
  • Zoledronic acid
  • Denosumab
  • Teriparatide
  • Abaloparatide
  • Other approved osteoporosis therapies

These medicines have different mechanisms, dosing schedules, contraindications and clinical indications, so they should not be substituted for EVENITY without a doctor's assessment.

12. SEO & B2B Keywords

  • EVENITY 105 mg Injection exporter from India
  • EVENITY 105 mg Injection supplier India
  • EVENITY 105 mg Injection pharmaceutical exporter
  • EVENITY 105 mg romosozumab injection supplier
  • Romosozumab 105 mg injection exporter
  • Romosozumab injection supplier from India
  • EVENITY 105 mg Injection wholesale supplier
  • EVENITY 105 mg Injection international supplier
  • EVENITY 105 mg osteoporosis injection
  • EVENITY romosozumab injection for osteoporosis
  • Severe osteoporosis treatment injection supplier
  • Osteoporosis injection pharmaceutical exporter India
  • Romosozumab medicine exporter from Nagpur
  • EVENITY medicine exporter from Nagpur India
  • EVENITY 105 mg Injection supplier to USA
  • EVENITY 105 mg Injection supplier to UK
  • EVENITY 105 mg Injection supplier to Australia
  • EVENITY 105 mg Injection supplier to Singapore
  • EVENITY 105 mg Injection supplier to Canada
  • EVENITY 105 mg Injection supplier to South Korea
  • EVENITY 105 mg Injection supplier to UAE
  • Genuine romosozumab 105 mg pharmaceutical supplier
  • Romosozumab osteoporosis medicine wholesale
  • EVENITY 105 mg pharmaceutical export from India
  • Prescription osteoporosis medicine exporter India
Aug 20th, 2026 3:51 PM

Keywords